Use of hemoglobin-based blood substitutes associated with increased risk of death, heart attack

An analysis of studies involving the use of hemoglobin-based blood substitutes indicates their use is associated with an increased risk of death and heart attack, according to a JAMA study being released early online, and will appear in print in the May 21 issue of JAMA.